Trial
NCT00256269
Oxaliplatin and Irinotecan in Recurrent or Metastatic Esophageal and Gastroesophageal (GE) Junction Carcinoma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of California, Irvine
Collaborators
Sanofi
Condition
Esophageal Cancer
Intervention
Oxaliplatin
Why stopped
Study was terminated by funding entity
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-01-26